Multiplex real–time RT–PCR for detecting chikungunya virus and dengue virus  by Pongsiri, Piyathida et al.
342 Asian Pacific Journal of Tropical Medicine (2012)342-346
Document heading          doi:  
Multiplex real-time RT-PCR for detecting chikungunya virus and 
dengue virus
Piyathida Pongsiri1, Kesmanee Praianantathavorn2, Apiradee Theamboonlers1, Sunchai 
Payungporn2, Yong Poovorawan1*
1Center of Excellence in Clinical Virology, Department of Pediatrics,  Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
2Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
 Contents lists available at ScienceDirect
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
ARTICLE INFO                           ABSTRACT
Article history:
Received 10 November 2011
Received in revised form 15 January 2011
Accepted 15 March 2012
Available online 20 May 2012
Keywords:
Multiplex
Real-time RT-PCR
Chikungunya virus
Dengue virus
  *Corresponding author: Profesor Yong Poovorawan, Center of Excellence in Clinical 
Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, 
Bangkok 10330 Thailand.
     Tel: +662-256-4929
     E-mail: Yong.P@chula.ac.th
    Foundation project: This study was supported by the Center of Excellence in Clinical 
Virology, Chulalongkorn University, CU Centenary Academic Development Project, King 
Chulalongkorn Memorial Hospital, the National Research University project of CHE and 
the Ratchadaphiseksonphot Endowment Fund (HR1155A).
1. Introduction
  Chikungunya virus (CHIKV) belongs to the family 
Togaviridae and the genus Alphavirus[1]. It contains a 
single-stranded RNA genome of approximately 11.8 kb 
and comprises three different strains: the East, Central 
and South African strain, West African strain and Asian 
strain[2]. Dengue virus (DENV) is a member of the family 
Flaviviridae, genus Flavivirus with a single-stranded 
RNA genome of 11 kb which has been categorized into 
four serotypes, DENV1-4[3]. Both viruses are arthropod-
borne viruses (arboviruses). Major mosquitoes vectors for 
the viruses are of the Aedes genus, including Aedes egypti 
and Aedes albopictus. Worldwide an estimated 50 million 
are infected with DENV per year, culminating in about
25 000 deaths in severe cases[4].  The magnitude of problems 
caused by the spreading of CHIKV can be seen in the 
unprecedented spread of CHIKV on islands of the Indian 
Ocean in 2005[5] and the largest recorded outbreak with 
more than 1.38 million cases in 2006-2007[6,7]. Recent 
endemic areas are mainly urban areas in South, East and 
West Africa, the south-western Indian Ocean islands, India 
and Asia including Thailand. The report showed that the 
recent CHIKV outbreak started spreading in Thailand in 
2008[8,9], and are of the ECSA strain confirmed by complete 
genome analysis[10,11].
  CHIKV causes chikungunya fever (CHIKF) in both male and 
female individuals of any age. CHIKF is self-limiting with a 
very low death rate and usually presents as a rapid onset of 
fever, a characteristic rash, severe and incapacitating joint 
pain and other less common symptoms such as headache, 
fatigue, nausea, vomiting and conjunctivitis[12]. The 
clinical characteristics of dengue vary from asymptomatic 
to potentially fatal complications. Dengue fever (DF) may 
present as headache, fever, bone or joint pain while dengue 
hemorrhagic fever (DHF) may produce bleeding, plasma 
leakage, fever, and thrombocytopenia which can affect 
any age. A plasma leakage test is crucial as DHF usually 
presents plasma leakage while DF does not. DHF may 
lead to dengue shock syndrome and must be monitored 
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closely[13]. 
  Discernment between DENV and CHIKV can be problematic 
because of their highly similar symptoms. For example, 
the Tanganyika (now Tanzania) epidemic of 1952-1953 was 
thought to be dengue infection while it was actually the first 
documented infection by CHIKV. A dengue-like epidemic 
on the Comoros Islands in 2005 was additionally a CHIKV 
outbreak[14,15]. Furthermore, the two viruses not only show 
similar symptoms to each other but also to other fever such 
as measles, influenza infection and severe acute respiratory 
syndrome[16]. The 2004 CHIKV epidemic in Kenya was 
originally thought to be malaria[17]. Additionally, there have 
been several reports of co-circulation and co-infection 
of CHIKV and DENV in Delhi, Malaysia, the Maldives and 
India along with the increasing number of travelers and the 
spread of the vectors, Aedes egypti and Aedes albopictus, for 
both viruses[18-20].
  Accurate and rapid diagnosis is critical, as this will 
facilitate treatment in case of atypical presentations and 
complications. Early distinction between dengue and other 
febrile illnesses could help identify patients with signs of 
DHF that could develop into life-threatening dengue shock 
syndrome. In addition, information on virus infections may 
contribute to the surveillance database and assist with 
molecular epidemiology research, as well as monitoring and 
aid in control of virus dissemination.
  CHIKV and DENV infections can be confirmed by direct 
detection such as virus propagation, reverse transcriptase-
polymerase chain reaction (RT-PCR) or real-time RT-PCR. 
Specific antibodies such as IgM or IgG (antibody capture 
ELISA) can be used to detect infection as well but they 
depend on the time of collection and availability. Real-
time RT-PCR has several advantages such as high sensitivity 
and specificity, ability to be performed in multiplex and 
is quantifiable. The objective of this study was to develop 
multiplex real-time RT-PCR based on Taqman chemistry for 
detection of CHIKV and DENV in a single tube reaction. We 
evaluated the sensitivity and specificity by comparison with 
conventional RT-PCR.  
2. Material and methods
  The research proposal has been approved by the ethics 
committee, Faculty of Medicine, Chulalongkorn University. 
All the study specimens were anonymized with coding 
numbers and permission granted by the directors of 
hospitals.
2.1. Case selection and Clinical samples
  RT-PCR confirmed CHIKV positive samples (n=39, 
accession number FJ882884-FJ882922)[9] and positive DENV 
(n=26, accession number JF274206-JF274231), which were 
then confirmed by RT-PCR and NS1 antigen rapid test (SD 
BIOLINE Dengue Duo, Kyonggi-do, Korea) were included in 
this study[21,22]. A total of 290 suspected cases were recruited 
in this study as well, comprised of acute serum samples 
collected within 7 days of the onset of illness, consistent with 
clinical diagnosis of dengue according to WHO criteria[23] 
and of CHIKV samples from suspected infections in the 
endemic area. Moreover, 28 hepatitis C positive, 2 hepatitis 
A positive, 6 hepatitis E positive, 2 Japanese encephalitis 
virus (JEV) samples were included in this study to evaluate 
sensitivity and specificity of this method.
2.2. Nucleic acid extraction and reverse transcription
  
  Viral RNA was extracted using a viral nucleic acid 
extraction kit (RBC Bioscience, Taipei, Taiwan) following 
the manufacturer’s specifications. The extracted RNA was 
stored at -80℃ until further use. RNA was transcribed into 
cDNA by using ImProm-IITM reverse transcriptase (Promega, 
Medison, WI). Briefly, the template was mixed with random 
primers diluted in RNase-free water. The mixture then was 
incubated at 70℃ for 5 minutes and quickly chilled at 4℃ 
for 5 minutes and then held on ice. Reverse Transcription 
Mix was added and annealing was performed at 25℃ for 
5 minutes, followed by extension at 42℃ for 60 minutes. 
Reverse transcriptase was inactivated by holding the 
mixture at 70℃ for 15 minutes.
2.3. Primer and probe design
  Fifteen CHIKV and 11 DENV nucleotide sequences were 
retrieved from GenBank and aligned using CLUSTAL W 
(http://www.ddbj.nig.ac.jp/searches-e.html). The sequence 
accession numbers were FJ807891, EU703762, AF192898, 
GU301779, GU301780, GU301781, FJ807893, FJ445511, 
AM258994, FJ513655, EU244823, FJ445492, FJ807896, NC004162, 
and AF192907 for CHIKV and HQ166035, GQ398255, GQ398265, 
GQ398266, FJ744718, FJ744719, GQ398257, FJ744740, FJ744734, 
AY618993, AY618992 for DENV. Primer and probe sequences 
are shown in Table 1.
2.4. Plasmid preparation 
  The target regions between positions 10237 and 10544 
Table 1
Nucleotide sequence of primers and probe used in the assay.
Virus Probe/primer Sequence (5’-3’) Region, position*
CHIKV
ChikF10378-10398 GCATCAGCTAAGCTCCGGGTC E1, 10378-10398
ChikR10487-10508 CAATGTCTTCAGCCTGGACACC E1, 10487-10508
ChikP10443-10456 Cy5-ATGCAAACGGCGACCATGCCGTCA--BBQ E1, 10433-10456
DENV
DenF10520-10541 GACTAGYGGTTAGAGGAGACC 3’UTR, 10520-10541
DenR10674-10694 GHRGAGACAGCAGGATCTCTG 3’UTR, 10674-10694
DenP10610-10634 JOE-AAGGACTAGMGGTTAGWGGAGACCC--BBQ 3’UTR, 10610-10634
*positions were approximated based on complete genome sequences.
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of the CHIKV E1 region and between positions 10019 and 
10695 of the DENV 3’ UTR (positions were approximated 
from complete genome) were amplified, sequenced, cloned 
into pGEM®-T Easy vector (Promega, Medison, WI) and 
transformed into Competent JM109 Escherichia coli, which 
were subsequently spread onto LB/ampicillin/IPTG/X-Gal 
plates and incubated overnight at 37℃. The white colonies 
(Escherichia coli with inserted region) were selected for 
further growth in LB broth. The plasmid was extracted 
using the HiYieldTM Plasmid Mini Kit (RBC Bioscience, 
Taipei, Taiwan). The presence of the inserted region and 
its direction were confirmed by PCR and direct sequencing 
and submitted to GenBank (Accession number JF297648- 
JF297652).
2.5. Thermal profile and optimization conditions 
  Separate reaction mixtures were carried out for each real-
time RT-PCR with parameters adjusted for each virus target. 
The amplification reaction was performed in a Corbett 
Research Rotor-Gene 3000 in a 10 毺L volume. The mixture 
contained 5 毺L of 2× reaction mix, 0.2 毺L of SuperScript
TM 
III RT/Platinum® Taq Mix, 0.5 毺M of ChikF10378-10398 
and ChikR10487-10508, 0.2 毺M of ChikP10443-10456,
0.25 毺M of DenF10520-10541 DenR10674-10694 and
0.125 毺M of DenP10610-10634, 1.25 mM of MgSO4,
1.4 毺L of distilled water and 1 毺L of template. Initial melt was 
at 95℃ for 2 minutes followed by 40 cycles of 95℃ (15 seconds),
55℃ (10 seconds), 60℃ (10 seconds) and 72℃ (20 seconds). 
Fluorescence signals were detected at the end of each 72℃ 
step. Subsequently, both real-time RT-PCR were combined 
to perform in a multiplex format.
2.6. Sensitivity and specificity compared with RT-PCR
  The clinical specimens were detected by conventional 
semi-nested RT-PCR using the primers previously defined 
by S. Chutinimitkul for DENV detection[24] and Naresh 
Kumar C.V.M. for CHIKV detection[25] and then compared 
to the real time RT-PCR for an evaluation of the sensitivity 
and specificity. Conventional RT-PCR serving as the reliable 
method because after RT-PCR, the result was confirmed 
by sequencing the PCR products and BLAST with GenBank 
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
3. Result
3.1. Design of primers and probes
  The specificity of primers and probes were tested against 
CHIKV and the four serotypes of DENV as shown in Figure 
1A and Figure 1B, respectively. The amplification plot of the 
Cy5 signal showed that only CHIKV could be amplified in 
the assay as the signal of DENV in the Cy5 channel remained 
low at the base line. Likewise, the JOE signal appeared for 
DENV1-4 at 10-13 cycles and there was no cross-reactive 
signal of CHIKV. The control reaction performed without 
template did not produce amplification as evidenced by the 
low level signal (Figure 1A and Figure 1B) suggesting that 
we were able to detect CHIKV and four serotypes of DENV 
successfully.
3.2. Sensitivity and specificity
  The result showed that our assay could detect all CHIKV 
and DENV confirmed positive samples and there was no 
signal for any of the other viruses tested. 
3.3. Evaluation of assay using clinical specimens 
  In a total of 290 clinical samples, conventional RT-PCR was 
used to detect CHIKV and DENV. The results of conventional 
RT-PCR showed that 125 samples were positive for either 
CHIKV or DENV. The sensitivity, specificity and accuracy 
of real time RT-PCR were 97.65%, 92.59% and 95.82%, 
respectively when compare to conventional RT-PCR.  Among 
125 positive samples, 60 samples were positive for CHIKV 
and 65 for DENV. All positive samples tested by conventional 
RT-PCR were also positive for real-time RT-PCR. Out of 162 
negative samples diagnosed by conventional RT-PCR, 12 
tested positive by real-time RT-PCR. As a result, real-time 
RT-PCR was found to be more sensitive than conventional 
RT-PCR.
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Figure 1. Amplification plot obtained for CHIKV and DENV1-4.
A: in Cy5 channel labeled for CHIKV probe; B: in JOE channel labeled for DENV probe.
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4. Discussion
  CHIKV and DENV diagnosis may be approached via several 
methods such as conventional RT-PCR, commercial rapid 
test, ELISA, HI test, virus culture and antibody screening 
(IgM, IgG). Screening for antibody of virus is commonly used 
but IgM of CHIKV may cross-react with other alphaviruses 
such as O’nyong nyong virus[26-28] and the antibody of DENV 
may cross react with other members of the Flaviviridae 
family such as JEV[29], resulting in false positives. Virus 
culture has shown reliable results but is laborious and time 
consuming to perform. To our knowledge, there is no method 
available to detect both viruses simultaneously and thus we 
have developed a method to detect CHIKV and DENV in a 
single tube. 
  The challenge of evaluating the assay is the difficulty in 
defining a gold standard for detecting the viral genome. 
Conventional RT-PCR has been traditionally used as the 
gold standard, but from our results real-time RT-PCR 
yields higher sensitivity than this method. Applying this 
assay, we were able to detect viral DNA at titers too low for 
amplification by normal RT-PCR (n=12). Additionally, real-
time RT-PCR also has an advantage over conventional RT-
PCR in terms of expediency. There are no post-amplification 
processes such as gel electrophoresis, gel visualization and 
sometimes confirmation by direct sequencing. Compared 
to semi-nested RT-PCR for DENV amplification, a two-step 
procedure, real-time RT-PCR requires less time to arrive 
at a diagnosis. By using multicolor probes, we were able to 
design oligonucleotide sequences of specific probes labeled 
with different colors[30]. Primers and probes were designed 
so that they could be used under similar amplification 
conditions but provide immediate viral identity feedback. 
Additionally, regional mutations were taken into account 
during the design process. During the largest outbreak of 
CHIKV on islands in the Indian Ocean, a signature mutation, 
E1-A226V, was found in the E1 region. Hence, we designed 
a set of primers and probe that do not target on this spot so 
that we are able to detect CHIKV regardless of E1-226 wild-
type or mutant. For DENV detection, our method is able 
to detect all four serotypes of DENV. Although detecting 
serotypes of DENV may be advantageous, the clinical 
treatments for all serotypes are identical and it may not be 
effective to use different probes to detect different serotypes. 
Evaluation of detection at minimum concentration revealed 
that this method can detect concentrations as low as 10 
copies/毺L. When testing the specificity of our assay, we 
found no cross reactivity between CHIKV, DENV, hepatitis 
C virus, hepatitis A virus, hepatitis E virus and JEV. Dual 
infection of CHIKV and DENV confirmed by conventional 
RT-PCR produced identical results with multiplex real-
time RT-PCR, suggesting that this method remains useful for 
detecting two viruses in a single step reaction. 
  In conclusion, our set of primers and probes allows for the 
rapid and early detection of CHIKV and DENV infection in a 
single step reaction. This method presents a useful tool for 
studying seroprevalence and quantitative determination of 
viral infection and may shed light on the correlation between 
clinical severity and immune response. Detection of CHIKV 
and DENV presents a challenge, as these viruses may only 
be traceable during the acute phase, 3-7 days post infection, 
making other techniques crucial in confirming infections. 
Awareness of virus dissemination will help the people to 
take preventive measures and the governments to develop 
vector control policies. 
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3.4. Limit of detection and standard curves
  We used template of known concentration to estimate the 
limit of detection for this method. The results showed that 
the minimum concentration was 10 copies/毺L for both 
CHIKV and DENV. Each concentration was plotted against Ct 
values as shown in Figure 2A and Figure 2B. The standard 
curves also showed a high correlation coefficient, R2= 0.994 
and 0.999 for CHIKV and DENV, respectively.
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